NovaBridge Biosciences

NASDAQ:NBP

Biotechnology

Healthcare
$0.90 -4.78%

-$0.07 today

Market cap
$104.10M
Beta
1.48
P/E (TTM)
-25.5
EPS (TTM)
-$0.40
52W Low $1.46High $6.79

Volume 0.87M

Average 0.90M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$20.60M

FY 2025 · Annual

Investing Cash Flow

$104.97M

FY 2025 · Annual

Financing Cash Flow

$57.73M

FY 2025 · Annual

Cash Flow Statement

Mixed currencies
Metric
FY2021
Dec 2021 · CNY
FY2022
Dec 2022 · CNY
FY2023
Dec 2023 · CNY
FY2024
Dec 2024 · CNY
FY2025
Dec 2025 · USD
Net Income(2.33B)(2.51B)(208.18M)(362.72M)(88.34M)
Depreciation & Amortization34.14M63.82M1.06M7.14M856K
Deferred Income Tax00000
Stock-Based Compensation608.61M357.15M10.26M(14.23M)5.97M
Change in Working Capital394.52M552.06M(37.2M)(20.52M)17.07M
Accounts Receivables97.42M33.08M000
Inventory(27.24M)27.24M000
Accounts Payables107.85M0000
Other Working Capital216.49M491.75M(37.2M)(20.52M)17.07M
Other Non-Cash Items321.18M431.48M161.2M5.9M43.84M
Operating Cash Flow(973.09M)(1.1B)(72.85M)(384.42M)(20.6M)
Capital Expenditures(29.93M)(45.83M)(164.35K)(350.34K)(7K)
Acquisitions (Net)(6M)0000
Purchases of Investments(10.17B)(7.41B)0(1.79B)(49.96M)
Sales of Investments9.48B7.91B0801.66M154.89M
Other Investing Activities026K(107.47M)452.53K47K
Investing Cash Flow(727.21M)458.38M(107.63M)(992.42M)104.97M
Debt Repayment02.75M000
Common Stock Issued000061.91M
Common Stock Repurchased0(3.08M)(8.66M)(2.45M)0
Dividends Paid00000
Other Financing Activities593.92M60.86M407.88K0(4.19M)
Financing Cash Flow593.92M42.36M(8.25M)(2.44M)57.73M
Effect of Forex Changes(128.77M)389.2M36.89M(327.04M)276K
Net Change in Cash(1.24B)(212.86M)(151.58M)(1.71B)142.37M
Free Cash Flow(1B)(1.15B)(73.02M)(384.77M)(20.6M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$88.3M
+ D&A$856.0K
+ Stock-Based Comp$6.0M
+ Deferred Tax$0
+ Working Capital$17.1M
+ Other Non-Cash$43.8M
= Operating Cash Flow-$20.6M
- Capex-$7.0K
= Free Cash Flow-$20.6M

Analysis

FY2025 free cash flow is -$20.6M. FCF conversion is 23.3% of net income. Operating cash flow was -$20.6M, with capex of -$7.0K. The largest bridge item is Other Non-Cash at $43.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 5, 2026
3Initial statement of beneficial ownershipNov 2, 2026
6-K6-K filingOct 28, 2026
6-K6-K filingOct 26, 2026
6-K6-K filingOct 23, 2026

Does NBP generate free cash flow?

NovaBridge Biosciences (NBP) generated -$20.60M of free cash flow in fiscal 2025.

How much operating cash flow does NBP produce?

Operating cash flow was -$20.60M, before capital expenditures of $7,000.00.